首页> 外文期刊>Molecular and Cellular Biochemistry: An International Journal for Chemical Biology >Association of L55M and Q192R polymorphisms in paraoxonase 1 (PON1) gene with breast cancer risk and their clinical significance.
【24h】

Association of L55M and Q192R polymorphisms in paraoxonase 1 (PON1) gene with breast cancer risk and their clinical significance.

机译:对氧磷酶1(PON1)基因的L55M和Q192R多态性与乳腺癌风险的关联及其临床意义。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The HDL-associated paraoxonase (PON) activities play a role in decreasing oxidative stress, which is known to contribute to cancer development. The aim of this study was to examine the relation between the PON1 L55M and Q192R polymorphisms and breast cancer (BC) risk in Egyptian females and to analyze their relation to clinicopathological parameters of BC. Both polymorphisms were characterized in 100 BC Egyptian females and 100 healthy women who had no history of any malignancy by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method, using DNA from peripheral blood in a case control study. With respect to PON1 L55M, the mutated allele (M) frequency was found in 70.5% in BC patients and in 53.5% in controls; the M allele was significantly associated with an increased risk of BC (adjusted odds ratio (OR(adj)) 2.07, 95% confidence interval (95% CI) 1.37-3.13; P = 0.011). The homozygous mutant genotype (MM) significantly increased the risk of BC (OR(adj) 2.07, 95% CI 1.17-3.64, P = 0.011). However, as regard PON1 Q192R, the R mutated allele frequency was found in 28.5% in BC patients and in 33% in controls, the women who were QR heterozygotes (OR(adj) 0.96, 95% CI 0.55-1.68) or RR homozygotes (OR(adj) 0.64, 95% CI 0.25-1.63), and R allele (OR(adj) 0.81, 95% CI 0.53-1.42) did not show any risk for BC. Both PON1 L55M and Q192R polymorphisms genotype frequencies were not related to patient's age (P = 0.94 and 0.72, respectively). M allele genotypes (LM/MM) carriers showed significant association only with nodal metastases (P = 0.02) but not with other clinicopathologic parameters. However, R allele genotype (QR/RR) carriers showed insignificant correlation with clinicopathological parameters. In conclusion, our results suggest that the M allele of L55M polymorphism could be a suitable marker for BC susceptibility and tumor prognosis in Egyptian women.
机译:与HDL相关的对氧磷酶(PON)的活性在降低氧化应激中起着一定作用,氧化应激被认为有助于癌症的发展。这项研究的目的是检查埃及女性中PON1 L55M和Q192R多态性与乳腺癌(BC)风险之间的关系,并分析其与BC临床病理参数的关系。在病例对照研究中,使用外周血中的DNA,通过聚合酶链反应-限制性片段长度多态性(PCR-RFLP)方法,对100例BC埃及女性和100例没有任何恶性病史的健康女性进行了两种多态性分析。对于PON1 L55M,在BC患者中发现突变的等位基因(M)频率为70.5%,在对照组中为53.5%。 M等位基因与BC风险增加显着相关(校正比值比(OR(adj))2.07,95%置信区间(95%CI)1.37-3.13; P = 0.011)。纯合突变基因型(MM)显着增加了BC的风险(OR(adj)2.07,95%CI 1.17-3.64,P = 0.011)。然而,关于PON1 Q192R,在BC患者中,QR杂合子(OR(adj)0.96,95%CI 0.55-1.68)或RR纯合子的女性中发现R突变的等位基因频率为28.5%,在对照组中为33%。 (OR(adj)0.64,95%CI 0.25-1.63)和R等位基因(OR(adj)0.81,95%CI 0.53-1.42)没有发现任何BC风险。 PON1 L55M和Q192R多态性基因型频率均与患者年龄无关(分别为P = 0.94和0.72)。 M等位基因型(LM / MM)携带者仅与淋巴结转移显着相关(P = 0.02),而与其他临床病理参数无关。但是,R等位基因基因型(QR / RR)携带者与临床病理参数无关。总之,我们的结果表明L55M多态性的M等位基因可能是埃及女性BC易感性和肿瘤预后的合适标志。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号